15 Years of Biosimilars: Improving Equitable Access to Essential and Affordable Biologic Medicines in Europe

The Biosimilar Medicines Group, a Medicines for Europe sector group, and Sandoz, a Novartis division, are delighted to invite you to a virtual event to celebrate the 15th anniversary of the first biosimilar medicine approval and launch worldwide.

Our lineup of top experts, stakeholders and policymakers from the field, include:
- Isabel de la Mata, Principal Advisor on Health and Crisis Management, DG SANTE, European Commission
- Zorana Maravic, CEO, Digestive Cancers Europe (DiCE)
- Peter Killian, Head of Pharmaceuticals, Association of Statutory Health Insurance Physicians in Bavaria
- Isabell Remus, Chair of the Biosimilar medicines Group, Medicines for Europe and Head Biopharma & Specialty Business Europe, Sandoz

The panel discussion will be moderated by Sue Saville, Journalist and Medical Correspondent. 

Join us to hear from these expert speakers discuss the impact of biosimilar medicines on patients’ lives over the last 15 years, and assess the future challenges and opportunities that will face the sector in the light of the revision of the EU pharmaceutical legislation and the implementation of the Europe’s Beating Cancer Plan.